Pharmaceutical and Research Unit, Department of Medical Services, Ministry of Health, Institute of Traditional Medicine Services, Thimphu, Bhutan.
Phytother Res. 2010 Apr;24(4):481-5. doi: 10.1002/ptr.2893.
The alkaloidal components of the Bhutanese medicinal plant Corydalis calliantha Long, which is used for the treatment of malaria, have been assessed. Four known alkaloids, protopine (1), scoulerine (2), cheilanthifoline (3) and stylopine (4) are reported from this plant for the first time. The protopine alkaloid, protopine, and the tetrahydroprotoberine alkaloid, cheilanthifoline, showed promising in vitro antiplasmodial activities against Plasmodium falciparum, both wild type (TM4) and multidrug resistant (K1) strains with IC(50) values in the range of 2.78-4.29 microM. Such activity had not been demonstrated previously for cheilanthifoline. The results thus support, at a molecular level, the clinical use of this plant in the Bhutanese traditional medicine and identified cheilanthifoline as a potential new antimalarial drug lead.
对用于治疗疟疾的不丹药用植物紫堇属 Calliantha 的生物碱成分进行了评估。首次从该植物中分离得到了 4 种已知的生物碱:原阿片碱(1)、刻叶紫堇明碱(2)、紫堇菲灵碱(3)和野罂粟碱(4)。原阿片碱和四氢原小檗碱类生物碱紫堇菲灵碱对恶性疟原虫野生株(TM4)和多药耐药株(K1)均显示出有希望的体外抗疟活性,IC50 值范围为 2.78-4.29 μM。此前,紫堇菲灵碱并未显示出这种活性。因此,这些结果在分子水平上支持了这种植物在不丹传统医学中的临床应用,并将紫堇菲灵碱鉴定为一种有潜力的新抗疟药物先导化合物。